Digital pathology developer BioImagene brought Siemens Venture Capital into its fold last week, adding an unreleased amount to a recently-closed $26 million fourth-round of financing. That round was led by Burill & Co. and included Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures.
The Cupertino, Calif.-based company helps laboratories view, manage and analyze images of pathologies. It provides tools to turn microscope slides into high-resolution images that can then be shared and transferred more easily, according to VentureWire.
The new funds come amid other big changes for the firm. It recently named Ajit Singh as its new chief executive. Singh previously served as chief executive of Siemens Healthcare's image and knowledge management division.